1. Home
  2. XTNT vs SCLX Comparison

XTNT vs SCLX Comparison

Compare XTNT & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

N/A

Current Price

$0.41

Market Cap

61.7M

Sector

Health Care

ML Signal

N/A

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$5.47

Market Cap

55.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XTNT
SCLX
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.7M
55.1M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
XTNT
SCLX
Price
$0.41
$5.47
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.00
N/A
AVG Volume (30 Days)
234.2K
45.9K
Earning Date
05-08-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
125.00
N/A
EPS
N/A
N/A
Revenue
$53,337,000.00
$30,253,000.00
Revenue This Year
N/A
$122.52
Revenue Next Year
$9.30
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$4.20
52 Week High
$0.95
$34.27

Technical Indicators

Market Signals
Indicator
XTNT
SCLX
Relative Strength Index (RSI) 44.91 33.26
Support Level $0.27 $5.48
Resistance Level $0.47 $7.77
Average True Range (ATR) 0.03 0.40
MACD 0.00 -0.04
Stochastic Oscillator 50.25 9.63

Price Performance

Historical Comparison
XTNT
SCLX

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: